Fishman Jay A LTD Tango Therapeutics, Inc. Transaction History

Fishman Jay A LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$6.66 - $10.15 $213,985 - $326,119	-32,130 Reduced 62.84%	19,000 $163,000
Q2 2024 Jul 31, 2024	BUY	$6.66 - $10.15 $180,685 - $275,369	27,130 Added 113.04%	51,130 $438,000
Q1 2024 Apr 23, 2024	BUY	$7.51 - $12.88 $75,100 - $128,800	10,000 Added 71.43%	24,000 $190,000
Q4 2023 Jan 24, 2024	BUY	$6.52 - $12.01 $91,280 - $168,140	14,000 New	14,000 $138,000
Q3 2023 Nov 13, 2023	SELL	$2.93 - $11.26 $17,580 - $67,560	-6,000 Reduced 30.0%	14,000 $157,000
Q2 2023 Aug 15, 2023	BUY	$2.67 - $4.7 $53,400 - $94,000	20,000 New	20,000 $66,000
Q4 2022 Feb 13, 2023	BUY	$3.41 - $8.29 $34,100 - $82,899	10,000 New	10,000 $72,000

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $320M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

Stay updated on Fishman Jay A LTD with notifications on news.